Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy Article

Hellmann, Matthew D., Janne, Pasi A., Opyrchal, Mateusz et al. (2021). Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy . CLINICAL CANCER RESEARCH, 27(4), 1019-1028. 10.1158/1078-0432.CCR-20-3305



Open Access Industry Collaboration

cited authors

  • Hellmann, Matthew D.; Janne, Pasi A.; Opyrchal, Mateusz; Hafez, Navid; Raez, Luis E.; Gabrilovich, Dmitry, I; Wang, Fang; Trepel, Jane B.; Lee, Min-Jung; Yuno, Akira; Lee, Sunmin; Brouwer, Susan; Sankoh, Serap; Wang, Lei; Tamang, David; Schmidt, Emmett, V; Meyers, Michael L.; Ramalingam, Suresh S.; Shum, Elaine; Ordentlich, Peter

fiu authors

publication date

  • February 15, 2021

webpage

published in

category

Digital Object Identifier (DOI)

start page

  • 1019

end page

  • 1028

volume

  • 27

issue

  • 4

SDG 03: Good Health and Well-being

  • true